Inhaled Glucocorticoids Products Return to Non-Preferred Status on September 18, 2020
FirstCare temporarily removed the non-preferred status on April 2 in response to reported drug shortages for medications in the "Glucocorticoids, Inhaled" drug class. FirstCare will reverse this change in status because of sufficient availability in the market. Beginning September 18, 2020 the formulary will reflect the PDL status changes for all non-preferred inhaled glucocorticoid products. For additional information and a list of preferred PDL NDCs please click here.
* Required field
ATTENTION: By clicking “Continue”, you will be leaving the FirstCare Medicare Dual SNP (HMO SNP) site pages. If you wish to remain on these pages, simply click “Cancel” or close this box.